Skip to main content
Back to IMM Investment

IMM Investment's Therapeutics Portfolio

Browse 11 Therapeutics companies funded by IMM Investment. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
11
Total Funding in Therapeutics
$284.6M

Therapeutics Portfolio Companies (11)

Export
BiotechnologyMedicalOncologyTherapeutics

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Cambridge, United States
April 2022
$20.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalNeuroscienceTherapeutics

Biotechnology, Neuorscience

Boston, United States
September 2023
$4.4M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Private biotech company creating cell penetrating therapeutic antibodies

Daejeon, South Korea
December 2025
$98.3M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics

Illimis Therapeutics is a science and technology company that develops treatment for degenerative brain and autoimmune diseases.

Seoul, South Korea
July 2025
$41.9M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

​Cellemedy is a biotechnology company that develops next-generation therapeutic proteins to replace conventional antibody treatments.

Seongnam, South Korea
October 2023
$7.4M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Zymedi is a pharmaceutical company that develops drugs for life-threatening diseases.

Ansan, South Korea
May 2023
$12.1M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyMedical DeviceOncologyTherapeutics

Pinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.

Suwon, South Korea
April 2023
$9.5M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareInformation TechnologyTherapeutics

AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden.

Seoul, South Korea
September 2022
$15.4M
Convertible Note

Founder Contacts

41,000+ verified contacts

Health DiagnosticsMedicalMobile AppsTherapeutics

LumanLab develops digital therapeutics to solve developmental delay problems.

Seoul, South Korea
June 2022
$2.4M
Seed

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

BIORCHESTRA creates novel RNA-based therapeutics that will usher in a new era of treatment for neurodegenerative diseases.

Yusong, South Korea
February 2022
$45.7M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

SCAI Therapeutics is a drug delivery platform bio-venture company for pharmaceutical industry.

Daejeon, South Korea
July 2021
$27.5M
Series B

Founder Contacts

41,000+ verified contacts

Explore IMM Investment's Full Portfolio

View all companies funded by IMM Investment across every industry and funding stage.

View Full IMM Investment Portfolio